Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$4.8 - $7.67 $4.33 Million - $6.91 Million
901,068 Added 7427.2%
913,200 $4.38 Million
Q3 2023

Nov 14, 2023

SELL
$6.81 - $9.74 $2.64 Million - $3.78 Million
-387,868 Reduced 96.97%
12,132 $87,000
Q2 2023

Aug 14, 2023

BUY
$6.67 - $9.52 $2.67 Million - $3.81 Million
400,000 New
400,000 $2.97 Million
Q1 2021

May 17, 2021

SELL
$112.98 - $319.93 $14.5 Million - $41 Million
-128,000 Reduced 39.54%
195,700 $35.5 Million
Q4 2020

Feb 12, 2021

SELL
$78.74 - $139.5 $4.07 Million - $7.21 Million
-51,700 Reduced 13.77%
323,700 $36.1 Million
Q3 2020

Nov 16, 2020

BUY
$79.44 - $178.51 $29.8 Million - $67 Million
375,400 New
375,400 $40.7 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.